Human Genetic Disease Applications

 

TessArray® provides a rapid, cost effective, customized approach for complex disease testing that is faster, easier, less expensive and less complicated to work with than Sanger Sequencing.

 

TessArae® uses existing microarray technology to do sequencing, which can replace capillary and gel based approaches.

 

•   • Proven technology – TessArae technology is being used in clinical labs and Affymetrix technology     has been used by thousands of labs worldwide.

    • Sensitive and accurate – data has been shown to be comparable to qPCR & Sanger sequencing

    • Better value than Sanger sequencing – Several genes can be sequences in one test

    • Faster turn around time - days vs. weeks

    • TessArray RDM Arrays perform routine repeat assays better than Sanger

    • Disease arrays completed or in development:

      Cystic Fibrosis

      Charcot-Marie-Tooth

      Noonan Syndrome

      Periodic Fever

      Various Cancers

 

This technology enables rapid (2 day turn-around) analysis of 10-15 genes (or # of base pairs) of your own choice. The sample handling process is routine, yielding more consistent results than current methodologies.

 

With TessArae's proprietary technology, final results are less ambiguous and far easier to interpret than typical Sanger approaches. Cost is approximately half of that of current processes.